A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer Contact Us Summary Our previous study indicated that intravenous vitamin C (IVC) treatment concurrent with modulated electrohyperthermia (mEHT) was safe and improved the quality of life (QoL) of non-small-cell lung cancer […]
Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea Contact Us Summary The study aims to evaluate the efficacy and safety of CIK cell immunotherapy with radiotherapy-temozolomide (TMZ) for the treatment of patients with glioblastoma. The addition of CIK cells immunotherapy to standard chemoradiotherapy with TMZ improved PFS. […]
Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients
Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients Contact Us Summary This study monitors the efficacy and safety of Modulated electro-hyperthermia (mEHT) for the treatment of advanced pancreatic cancer. Pancreatic adenocarcinoma has a poor prognosis, resulting in a <10% survival rate at 5 years;However, The result suggests, mEHT […]
Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer
Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer Contact Us Summary This study investigates, DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 agonist poly-ICLC, as a promising approach for harnessing immunity against metastatic or locally advanced unresectable pancreatic cancer (PC). As a result, the treatment was well-tolerated, with the most […]
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study Contact Us Summary This study investigates the effects of Electro-hyperthermia on patients with pancreatic ductal adenocarcinoma (PDAC), supporting the perspectives with the improvements of the treatment possibilities. A trend in favor of mEHT was found in overall survival. mEHT treatment […]
Beneficial effects of modulated Electro- Hyperthermia during neoadjuvant treatment for locally advanced Rectal Cancer
Beneficial effects of modulated Electro- Hyperthermia during neoadjuvant treatment for locally advanced Rectal Cancer Contact Us Summary This study investigated the role of electro-hyperthermia (mEHT) with neoadjuvant therapy for locally advanced rectal cancer. As a result the overall mEHT group had a comparable response and survival using less radiation dosing compared with standard care. Patients […]
